BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14579287)

  • 1. The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses.
    Plant A; Williams R; Jackson ME; Williams NA
    Eur J Immunol; 2003 Nov; 33(11):3186-95. PubMed ID: 14579287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation.
    Apostolaki M; Williams NA
    Infect Immun; 2004 Jul; 72(7):4072-80. PubMed ID: 15213152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences.
    Turcanu V; Hirst TR; Williams NA
    Immunology; 2002 Jul; 106(3):316-25. PubMed ID: 12100719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.
    Nashar TO; Webb HM; Eaglestone S; Williams NA; Hirst TR
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):226-30. PubMed ID: 8552610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1.
    Nashar TO; Hirst TR; Williams NA
    Immunology; 1997 Aug; 91(4):572-8. PubMed ID: 9378497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells.
    Luross JA; Heaton T; Hirst TR; Day MJ; Williams NA
    Arthritis Rheum; 2002 Jun; 46(6):1671-82. PubMed ID: 12115200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.
    Clements JD; Hartzog NM; Lyon FL
    Vaccine; 1988 Jun; 6(3):269-77. PubMed ID: 3048010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
    Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells.
    Donaldson DS; Apostolaki M; Bone HK; Richards CM; Williams NA
    Mucosal Immunol; 2013 May; 6(3):535-46. PubMed ID: 23032791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.
    Nakagawa I; Takahashi I; Kiyono H; McGhee JR; Hamada S
    J Infect Dis; 1996 Jun; 173(6):1428-36. PubMed ID: 8648216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin.
    Bone H; Eckholdt S; Williams NA
    Int Immunol; 2002 Jun; 14(6):647-58. PubMed ID: 12039916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.
    Castagliuolo I; Sardina M; Brun P; DeRos C; Mastrotto C; Lovato L; Palù G
    Infect Immun; 2004 May; 72(5):2827-36. PubMed ID: 15102793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Display of an inhibin epitope in a surface-exposed loop of the E. coli heat-labile enterotoxin B subunit.
    Sewani CR; Bagdasarian MM; Ireland JJ; Bagdasarian M
    Vaccine; 1998 Oct; 16(17):1611-9. PubMed ID: 9713936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.
    Brereton CF; Sutton CE; Ross PJ; Iwakura Y; Pizza M; Rappuoli R; Lavelle EC; Mills KH
    J Immunol; 2011 May; 186(10):5896-906. PubMed ID: 21490151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A universal polysaccharide conjugated vaccine against O111 E. coli.
    Andrade GR; New RR; Sant'Anna OA; Williams NA; Alves RC; Pimenta DC; Vigerelli H; Melo BS; Rocha LB; Piazza RM; Mendonça-Previato L; Domingos MO
    Hum Vaccin Immunother; 2014; 10(10):2864-74. PubMed ID: 25483465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal administration of the B subunit of E. coli heat-labile enterotoxin promotes the development of Foxp3-expressing regulatory T cells.
    Donaldson DS; Tong KK; Williams NA
    Mucosal Immunol; 2011 Mar; 4(2):227-38. PubMed ID: 20944556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
    APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.